youth anxiety disorders
Related entities
Findings (27)
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0
None
improvementBoth combination treatment and sertraline monotherapy were superior to placebo at week 12 on parent-reported internalizing psychopathology, while CBT alone was not.
Effect: improvement; COMB: b=-5.7, t=3.4; SRT: b=-6.8, t=4.0